← All organizations

Grupo Español de Investigación en Cáncer de Ovario

Academic/HospitalWebsite ↗

Also known as: Grupo Español de Investigación en Cáncer de Ovario

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2025

Timeline

1990s

Jan 1, 1999
Grupo Español de Investigación en Cáncer de Ovario— Founded

Drugs by trial phase (18 distinct, 16 trials)

Phase 3 (12 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT07013851Lead sponsorPhase 2Oct 1, 2025
NCT05611931CollaboratorPhase 3Nov 1, 2022
NCT03833479Lead sponsorPhase 2Jul 31, 2019
NCT03598270Lead sponsorPhase 3Nov 30, 2018
NCT03556839Lead sponsorPhase 3Sep 25, 2018
NCT03470805Lead sponsorPhase 2Jun 21, 2018
NCT03161132Lead sponsorPhase 2Jun 1, 2017
NCT02730429CollaboratorPhase 2Feb 15, 2017
NCT02477644CollaboratorPhase 3May 1, 2015
NCT02009579CollaboratorPhase 2Mar 1, 2014
NCT01847677Lead sponsorPhase 2Apr 1, 2013
NCT01262014Lead sponsorPhase 2Dec 1, 2010
NCT01246440Reponsible party - principal investigatorPhase 2Jun 1, 2010
NCT01246440Lead sponsorPhase 2Jun 1, 2010
NCT00993655CollaboratorPhase 2Sep 1, 2009

Details

Founded: Madrid, ES Jan 1, 1999
Last known activity: Oct 1, 2025